Investment Column: Back Cenkos to wade through the treacle


Cenkos

Our view: Buy

Share price: 88p (-8p)

Life is not easy for the brokers who make their living looking after the smaller and medium-sized companies that bulge bracket investment banks largely turn their noses up at.

The market for flotations and M&A work has certainly improved from the dark days of the credit crunch, but the good times are a long way from being back. That is reflected in the way shares in Cenkos Securities have performed – and to add to those woes, yesterday chief executive Simon Melling announced he was stepping down.

Mr Melling wants to take a break, though he will run the business until a successor is found and is dismissive of talk of boardroom ructions. But he warns that, while the third quarter has only just started, trading can already be described as "treacly".

Still, Cenkos is fortunate in that it has a flexible cost base. It has resisted pressure to raise basic salaries along the lines of larger rivals. The pay of Cenkos staff is therefore closely matched to the company's performance. If it does well, they get a bonus. But there are none of the guarantees that caused so many problems among the big boys and this is not a company that presents "systemic risk" to the markets. For investors, that's no bad thing.

Still, though Mr Melling remains confident Cenkos can trade profitably throughout the remainder of the year, the shares remain a risky play. The small and mid-cap companies which Cenkos looks after are far more dependent on the performance of the stuttering UK economy than larger rivals, though Cenkos has worked to cushion that by developing business overseas, bringing a number of Asian companies to the UK market.

These shares are starting to look cheap at about eight times forecast full-year earnings. The dividend was cut last year, but should be raised if earnings improve, although yield is not something to count on. Mr Melling's impending departure, combined with the shaky economic climate, means the business faces significant uncertainties. But there is a buying opportunity here for those willing to roll the dice.



Genus

Our view: buy

Share price: 1,032 (-8p)

It is hard to avoid puns when taking a look at Genus, but the animal genetics company has been in rather a bullish mood recently. When it updated the market back in May, the Basingstoke-based group – which supplies both breeding pigs and high-quality bull semen to farmers – said it was on track to beat the previous 12 months, and yesterday's brief pre-close trading statement ahead of September's full-year results confirmed that view.

The company believes it will meet market expectations, with analysts predicting a £38m pre-tax profit. This is despite its customers having been hit by the rising cost of feed, with Genus saying farmers have managed to make up for this with increased output prices. For years the company's star asset has been a bull called Picston Shottle, but the Holstein Friesian is approaching retirement, as is Genus' chief executive, Richard Wood.

Announced in May, after 14 years at the helm – during which time he oversaw the floating of the company and its promotion to the FTSE 250 – Mr Wood is saying farewell in September.

For his replacement – Karim Bitar, the European head of the US drug maker Eli Lilly – the task will be to steer Genus' continued growth, set to be driven through expanding its presence in emerging markets as well as further technological innovations, with it hopeful on the ongoing development of a way to more efficiently separate male and female sperm.

Yesterday, the shares dipped 8p to 1,032p, but after gains of 20 per cent in 2011 – and more than 100 per cent over the last two years – we suspect some profit taking. The support behind the stock remains. Buy.

Start your day with The Independent, sign up for daily news emails
News
ebooksAn unforgettable anthology of contemporary reportage
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Digital Optimisation Executive - Marketing

£30000 - £35000 per annum: Recruitment Genius: The UK's fastest growing, multi...

Recruitment Genius: Financial Reporting Manager

£70000 - £90000 per annum: Recruitment Genius: A Financial Reporting Manager i...

Recruitment Genius: Payments Operations Assistant

£23000 - £25000 per annum: Recruitment Genius: They win lots of awards for the...

Recruitment Genius: Telephone Debt Negotiator

£13500 - £20000 per annum: Recruitment Genius: This nationwide enforcement com...

Day In a Page

Syria civil war: Meet the military commander who says his soldiers will not rest until every inch of their war torn country is free of Islamist 'terrorists'

‘We won’t stop until Syria is back to normal’

Near the front lines with Islamist-controlled towns where Assad’s troops were besieged just last month, Robert Fisk meets a commander confidently preparing his soldiers for battle
The inside story of how Bill Clinton built a $2bn global foundation may undermine Hillary's chances

The inside story of how Bill Clinton built a $2bn global foundation...

... and how it may undermine Hillary's chances in 2016
12 best olive oils

Extra-virgin, cold-press, early-harvest, ultra-premium: 12 best olive oils

Choosing an olive oil is a surprising minefield. Save yourself the hassle with our handy guide
Sepp Blatter resignation: The beginning of Fifa's long road to reform?

Does Blatter's departure mean Fifa will automatically clean up its act?

Don't bet on it, says Tom Peck
Charles Kennedy: The baby of the House who grew into a Lib Dem giant

The baby of the House who grew into a Lib Dem giant

Charles Kennedy was consistently a man of the centre-left, dedicated to social justice, but was also a champion of liberty and an opponent of the nanny-state, says Baroness Williams
Syria civil war: The harrowing testament of a five-year-old victim of this endless conflict

The harrowing testament of a five-year-old victim of Syria's endless civil war

Sahar Qanbar lost her mother and brother as civilians and government soldiers fought side by side after being surrounded by brutal Islamist fighters. Robert Fisk visited her
The future of songwriting: How streaming is changing everything we know about making music

The future of songwriting

How streaming is changing everything we know about making music
William Shemin and Henry Johnson: Jewish and black soldiers receive World War I Medal of Honor amid claims of discrimination

Recognition at long last

Jewish and black soldiers who fought in WWI finally receive medals after claims of discrimination
Beating obesity: The new pacemaker which helps over-eaters

Beating obesity

The new pacemaker which helps over-eaters
9 best women's festival waterproofs

Ready for rain: 9 best women's festival waterproofs

These are the macs to keep your denim dry and your hair frizz-free(ish)
Cycling World Hour Record: Nervous Sir Bradley Wiggins ready for pain as he prepares to go distance

Wiggins worried

Nervous Sir Bradley ready for pain as he prepares to attempt cycling's World Hour Record
Liverpool close in on Milner signing

Liverpool close in on Milner signing

Reds baulk at Christian Benteke £32.5m release clause
On your feet! Spending at least two hours a day standing reduces the risk of heart attacks, cancer and diabetes, according to new research

On your feet!

Spending half the day standing 'reduces risk of heart attacks and cancer'
With scores of surgeries closing, what hope is there for the David Cameron's promise of 5,000 more GPs and a 24/7 NHS?

The big NHS question

Why are there so few new GPs when so many want to study medicine?
Big knickers are back: Thongs ain't what they used to be

Thongs ain't what they used to be

Big knickers are back